Eloctate Kit
Product Images NDC 71104-803

Product Visual Gallery

This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Eloctate (NDC 71104-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bioverativ Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Elo04 0001 01)

Instructional illustration showing a person using their fingers to lift the protective foil seal from a small container or vial, demonstrating how to open the packaging.*

FDA Label Image

Figure (Elo04 0001 02)

An instructional illustration showing a hand pressing down on the top of a vial with downward arrows indicating the action of pressing or securing the vial's cap. The image likely demonstrates a step in preparing or accessing the vial contents, consistent with medication kit usage.*

FDA Label Image

Figure (Elo04 0001 03)

An instructional illustration showing a hand removing a flip-off cap from the top of a vial, demonstrating the first step in preparing ELOCTATE kit for intravenous administration.*

FDA Label Image

Figure (Elo04 0001 04)

An instructional illustration showing a hand attaching a syringe to a vial adaptor by twisting it in a clockwise direction, likely depicting a step in preparing an intravenous medication kit such as ELOCTATE (Antihemophilic Factor, Recombinant).*

FDA Label Image

Figure (Elo04 0001 05)

An instructional illustration showing components of the ELOCTATE intravenous kit by Bioverativ Therapeutics Inc. The image depicts a vial adapter in its package, a vial containing powdered drug, and a prefilled diluent syringe with an accompanying plunger rod, illustrating the parts used for drug preparation and administration.*

FDA Label Image

Figure (Elo04 0001 06)

An instructional illustration showing hands opening a vial by pressing down and twisting the vial cap. The diagram demonstrates the correct technique for vial cap removal in a stepwise manner.*

FDA Label Image

Figure (Elo04 0001 07)

An instructional diagram showing hands holding a mixing container while peeling back the seal of a vial or powder blister. The illustration demonstrates the initial step of preparing a medication kit, presumably for ELOCTATE, an intravenous antihemophilic factor recombinant product by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Elo04 0001 08)

An instructional illustration showing a hand pressing down on a round plastic component, likely part of a medical kit assembly process. It demonstrates the action of securing or connecting parts, relevant to intravenous kit preparation.*

FDA Label Image

Figure (Elo04 0001 09)

Instructional illustration showing hands removing a cap from a vial. The image highlights the upward removal motion with an arrow, indicating part of vial preparation or usage steps.*

FDA Label Image

Figure (Elo04 0001 10)

Instructional illustration showing a hand manipulating a syringe and a vial, demonstrating the assembly or preparation process for a medication, likely related to intravenous administration.*

FDA Label Image

Figure (Elo04 0001 11)

An instructional illustration showing a hand holding a small vial or syringe with a clear liquid inside, likely depicting preparation or administration related to the ELOCTATE intravenous kit by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Elo04 0001 12)

An instructional illustration showing a step for preparing an intravenous kit. It depicts a hand holding a vial with a cap being removed using the thumb and forefinger, with an arrow indicating motion to lift the cap, accompanied by another hand stabilizing the vial. A small inset shows a close-up of removing the vial cap. The drawing uses simple line art with colored highlights.*

FDA Label Image

Figure (Elo04 0001 13)

An instructional illustration showing hands adjusting or twisting a component of a medical device, likely for intravenous administration, as part of the preparation or use of ELOCTATE kit. The image emphasizes hand positioning and rotation direction to operate the device.*

FDA Label Image

Figure (Elo04 0001 14)

An instructional illustration showing two hands assembling a syringe by attaching it to a vial or similar container, with a downward arrow indicating the direction to push the syringe onto the vial.*

FDA Label Image

Figure (Elo04 0001 15)

An instructional illustration showing a hand holding and twisting a medical device, likely part of an intravenous drug kit. The image depicts the process of turning a component, indicated by purple circular arrows, representing assembly or preparation steps for intravenous administration.*

FDA Label Image

Figure (Elo04 0001 16)

A text panel containing an instruction that advises users to stop and refer to pooling instructions on the back if using more than one vial. The text is set against a purple background with white font.*

FDA Label Image

Figure (Elo04 0001 17)

An instructional illustration showing two steps for assembling or preparing a syringe and vial setup. The left panel depicts a hand placing a vial adapter onto a vial, while the right panel shows a hand pulling back the syringe plunger. This image likely relates to preparation for intravenous administration.*

FDA Label Image

Figure (Elo04 0001 18)

An instructional illustration showing a person holding a vial and inserting it into a syringe with an arrow indicating the direction for combining or drawing liquid. This image demonstrates a step in medication preparation, likely related to the intravenous kit form of ELOCTATE (Antihemophilic Factor, Recombinant, Fc Fusion Protein).*

FDA Label Image

Figure (Elo04 0001 19)

Instructional image with a purple banner containing white text stating "TURN OVER FOR POOLING AND ADMINISTRATION," indicating instructions for use related to the product ELOCTATE (Antihemophilic Factor (Recombinant), Fc Fusion Protein) kit.*

FDA Label Image

Figure (Elo04 0001 20)

Label panel from ELOCTATE kit, showing instruction to turn over to the front side for reconstitution. The label features a purple background with white text.*

FDA Label Image

Figure (Elo04 0001 21)

An instructional illustration showing a hand holding a vial and another hand using a syringe to withdraw medication. The syringe is being twisted or aligned with the vial, indicated by a curved arrow, demonstrating preparation steps for intravenous administration.*

FDA Label Image

Figure (Elo04 0001 22)

An instructional illustration showing two hands assembling or manipulating a syringe connected to a vial or adapter, with a purple arrow indicating a twisting motion. The image likely demonstrates how to prepare or connect parts of an intravenous medication kit.*

FDA Label Image

Figure (Elo04 0001 23)

An instructional illustration showing a hand holding a syringe connected to a vial, demonstrating the process of drawing medication from the vial. An arrow points downward, indicating the direction for pulling the plunger to withdraw the liquid. This relates to preparation of an intravenous medication.*

FDA Label Image

Figure (Elo04 0001 24)

An instructional illustration showing a hand holding a vial and another hand attaching or disconnecting a purple-tipped syringe or connector, likely demonstrating preparation or administration steps related to the ELOCTATE intravenous kit.*

FDA Label Image

Figure (Elo04 0001 25)

An instructional illustration showing a person using their opposite hand to apply pressure or perform an action on the inner side of their forearm. The image likely demonstrates a technique related to intravenous administration or vein location.*

FDA Label Image

Figure (Elo04 0001 26)

An instructional illustration showing two hands connecting an intravenous (IV) line setup. One hand holds an IV syringe or needle, while the other inserts or connects the tubing, indicating the preparation or administration process for an intravenous medication.*

FDA Label Image

Figure (Elo04 0001 27)

An instructional illustration showing a person applying adhesive tape to the site of an intravenous injection on their arm. The image depicts a hand securing the tape over the insertion site to hold the IV catheter or needle in place.*

FDA Label Image

Figure (Elo04 0001 28)

An instructional illustration showing an intravenous injection into a forearm, with a needle inserted into a vein and an arrow indicating the direction of syringe plunger movement. The image depicts the process of administering an intravenous infusion, relevant to the product ELOCTATE, an Antihemophilic Factor (Recombinant), Fc Fusion Protein kit.*

FDA Label Image

Figure (Elo04 0001 29)

An instructional illustration showing a hand applying a cleansing wipe to the forearm. The image depicts a preparatory step, likely for intravenous administration, consistent with the route of administration for ELOCTATE, an Antihemophilic Factor (Recombinant), Fc Fusion Protein kit.*

FDA Label Image

Principal Display Panel (250 IU Nominal Carton Label)

ELOCTATE KIT packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein, for intravenous administration. The label indicates a nominal strength of 250 IU. The label includes manufacturer information for Bioverativ Therapeutics Inc., directions for storage and administration, a barcode, and instructions to record the carton removal date from refrigeration.*

FDA Label Image

Principal Display Panel (500 IU Nominal Carton Label)

ELOCTATE kit packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein, labeled for intravenous administration. The label specifies a 500 IU nominal strength and includes contents: single-dose vial with lyophilized powder, prefilled diluent syringe, sterile vial adapter, and package insert. Manufactured by Bioverativ Therapeutics Inc., Waltham, MA. Instructions for storage, administration, and product reconstitution are detailed, along with barcode and NDC 71104-802-01.*

FDA Label Image

Principal Display Panel (750 IU Nominal Carton Label)

ELOCTATE 750 IU Nominal kit label for Antihemophilic Factor (Recombinant), Fc Fusion Protein by Bioverativ Therapeutics Inc. The packaging indicates it is for intravenous administration and includes a single-dose vial with lyophilized powder, a prefilled diluent syringe containing 3 mL sterile water, a sterile vial adapter reconstitution device, and a package insert. Storage instructions specify refrigeration between 2°C to 8°C and protection from freezing and light.*

FDA Label Image

Principal Display Panel (1000 IU Nominal Carton Label)

ELOCTATE 1000 IU Nominal kit packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein for intravenous administration. The label details the kit contents including single-dose vial, prefilled diluent syringe, reconstitution device, and package insert. Manufactured by Bioverativ Therapeutics Inc., with storage instructions and composition information on the sides.*

FDA Label Image

Principal Display Panel (1500 IU Nominal Carton Label)

Packaging label for ELOCTATE kit containing Antihemophilic Factor (Recombinant), Fc Fusion Protein for intravenous administration. The kit contains 1500 IU nominal strength. Label includes storage instructions, dosing directions, and contents: single-dose vial with lyophilized powder, prefilled diluent syringe with 3 mL sterile water, sterile vial adapter, and package insert. Manufactured by Bioverativ Therapeutics Inc., Waltham, MA.*

FDA Label Image

Principal Display Panel (2000 IU Nominal Carton Label)

ELOCTATE kit packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein for intravenous administration. The label indicates a 2000 IU nominal strength, includes contents such as lyophilized powder, a prefilled syringe with sterile water, and a sterile vial adapter. Manufactured by Bioverativ Therapeutics Inc., it directs storage under controlled refrigeration and provides reconstitution instructions.*

FDA Label Image

Principal Display Panel (3000 IU Nominal Carton Label)

ELOCTATE 3000 IU Nominal KIT packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein, for intravenous administration. The label includes dosage and administration instructions, storage conditions, and contents: one single-dose vial with lyophilized powder, one 3 mL prefilled diluent syringe, a sterile vial adapter, and package insert. Manufactured by Bioverativ Therapeutics Inc. with contact and regulatory information.*

FDA Label Image

Principal Display Panel (4000 IU Nominal Carton Label)

Packaging label for ELOCTATE 4000 IU Nominal, an Antihemophilic Factor (Recombinant), Fc Fusion Protein kit for intravenous administration. The label includes storage instructions, contents of the package, manufacturer Bioverativ Therapeutics Inc., and a barcode. The package contains a single-dose vial, 3 mL prefilled diluent syringe, sterile vial adapter, and package insert.*

FDA Label Image

Principal Display Panel (5000 IU Nominal Carton Label)

Packaging label for ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, a plasma derivative kit for intravenous administration. The label indicates a nominal strength of 5000 IU and includes contents such as a single-dose vial with lyophilized powder, a prefilled diluent syringe, a reconstitution device, and a package insert. Manufactured by Bioverativ Therapeutics Inc., Waltham, MA 02451. Storage and handling instructions are detailed on the label.*

FDA Label Image

Principal Display Panel (6000 IU Nominal Carton Label)

ELOCTATE 6000 IU Nominal kit packaging label for Antihemophilic Factor (Recombinant), Fc Fusion Protein for intravenous administration. The label includes dosage and storage instructions, manufacturer details (Bioverativ Therapeutics Inc.), and contents of the package such as a single-dose vial with lyophilized powder, a prefilled diluent syringe, a sterile vial adapter, and a package insert. The label also features a barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.